Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma | Zendy

Meletios Α. Dimopoulos | Zendy; Albert Oriol | Zendy; Hareth Nahi | Zendy; Jesús F. San Miguel | Zendy; Nizar J. Bahlis | Zendy; Saad Z. Usmani | Zendy; Neil Rabin | Zendy; Robert Z. Orlowski | Zendy; Mieczysław Komarnicki | Zendy; Kenshi Suzuki | Zendy; Torben Plesner | Zendy; SungSoo Yoon | Zendy; Dina Ben Yehuda | Zendy; Paul G. Richardson | Zendy; Hartmut Goldschmidt | Zendy; Donna Reece | Zendy; Steen Lisby | Zendy; Nushmia Z. Khokhar | Zendy; Lisa O’Rourke | Zendy; Christopher Chiu | Zendy; Xiang Qin | Zendy; Mary Guckert | Zendy; Tahamtan Ahmadi | Zendy; Philippe Moreau | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Author(s) -

Meletios Α. Dimopoulos,

Albert Oriol,

Hareth Nahi,

Jesús F. San Miguel,

Nizar J. Bahlis,

Saad Z. Usmani,

Neil Rabin,

Robert Z. Orlowski,

Mieczysław Komarnicki,

Kenshi Suzuki,

Torben Plesner,

SungSoo Yoon,

Dina Ben Yehuda,

Paul G. Richardson,

Hartmut Goldschmidt,

Donna Reece,

Steen Lisby,

Nushmia Z. Khokhar,

Lisa O’Rourke,

Christopher Chiu,

Xiang Qin,

Mary Guckert,

Tahamtan Ahmadi,

Philippe Moreau

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1607751

Subject(s) - daratumumab , lenalidomide , medicine , dexamethasone , multiple myeloma , oncology

Daratumumab showed promising efficacy alone and with lenalidomide and dexamethasone in a phase 1-2 study involving patients with relapsed or refractory multiple myeloma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore